These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16171734)

  • 41. Attitudes and prescribing preferences of health care professionals in the United States regarding use of extended-cycle oral contraceptives.
    Sulak PJ; Buckley T; Kuehl TJ
    Contraception; 2006 Jan; 73(1):41-5. PubMed ID: 16371293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 microg of ethinyl estradiol.
    Greco T; Graham CA; Bancroft J; Tanner A; Doll HA
    Contraception; 2007 Jul; 76(1):8-17. PubMed ID: 17586130
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA; Norman H; Doherty M; Walker AM
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Performance of contraceptive patch compared with oral contraceptive pill in a high-risk population.
    Bakhru A; Stanwood N
    Obstet Gynecol; 2006 Aug; 108(2):378-86. PubMed ID: 16880309
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary report on characteristics of women participating in the meeting of the Oral Contraceptive Pill Members Club at Siriraj Hospital.
    Thamkhantho M; Jivasak-Apimas S; Chiravacharadej G; Inthawong J; Butrpetch K; Harnnarong B
    J Med Assoc Thai; 2008 Jun; 91(6):781-6. PubMed ID: 18697373
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Initiation of oral contraceptives using a quick start compared with a conventional start: a randomized controlled trial.
    Westhoff C; Heartwell S; Edwards S; Zieman M; Cushman L; Robilotto C; Stuart G; Morroni C; Kalmuss D
    Obstet Gynecol; 2007 Jun; 109(6):1270-6. PubMed ID: 17540797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days.
    Foidart JM; Sulak PJ; Schellschmidt I; Zimmermann D;
    Contraception; 2006 Jan; 73(1):34-40. PubMed ID: 16371292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spanish women's attitudes towards menstruation and use of a continuous, daily use hormonal combined contraceptive regimen.
    Sánchez-Borrego R; García-Calvo C
    Contraception; 2008 Feb; 77(2):114-7. PubMed ID: 18226675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [State of the hypothalamo-hypophyseal-ovarian system in young nullipara women with ectopia of the cervix of uterus during taking the hormonal contraceptives].
    Djangidze M; Djugeli M; Museridze N; Zakaraia L
    Georgian Med News; 2007 Oct; (151):26-31. PubMed ID: 18071207
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Androgenicity of the progestin in oral contraceptives does not affect maximal leg strength.
    Peters C; Burrows M
    Contraception; 2006 Dec; 74(6):487-91. PubMed ID: 17157107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
    Thurman AR; Hammond N; Brown HE; Roddy ME
    J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.
    Kluft C; Endrikat J; Mulder SM; Gerlinger C; Heithecker R
    Contraception; 2006 Apr; 73(4):336-43. PubMed ID: 16531162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives.
    Hampton RM; Zhang HF; Barnowski C; Wan GJ
    Contraception; 2008 Jun; 77(6):415-9. PubMed ID: 18477490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contraceptive vaginal ring use for women has less adverse metabolic effects than an oral contraceptive.
    Elkind-Hirsch KE; Darensbourg C; Ogden B; Ogden LF; Hindelang P
    Contraception; 2007 Nov; 76(5):348-56. PubMed ID: 17963858
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
    Ahrendt HJ; Nisand I; Bastianelli C; Gómez MA; Gemzell-Danielsson K; Urdl W; Karskov B; Oeyen L; Bitzer J; Page G; Milsom I
    Contraception; 2006 Dec; 74(6):451-7. PubMed ID: 17157101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is the process of diagnosing and treating incidental medical findings a barrier to contraceptive acceptance and use?
    Ekabua JE; Ekabua KJ; Ekanem EI; Iklaki CU
    J Obstet Gynaecol; 2009 Apr; 29(3):237-9. PubMed ID: 19358034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factors affecting women's selection of a combined hormonal contraceptive method: the TEAM-06 Spanish cross-sectional study.
    Lete I; Doval JL; Pérez-Campos E; Sánchez-Borrego R; Correa M; de la Viuda E; Gómez MA; González JV; Lertxundi R; Martínez MT; Mendoza N; Robledo J
    Contraception; 2007 Aug; 76(2):77-83. PubMed ID: 17656174
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A clinical study of transdermal contraceptive patch in Thai women.
    Suwanmalee O; Taneepanichskul S
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S1-4. PubMed ID: 17726805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
    Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
    Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives.
    Benagiano G; Carrara S; Filippi V
    Patient Prefer Adherence; 2009 Nov; 3():131-43. PubMed ID: 19936155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.